Urinary Retention from Medications: How Anticholinergics Can Stop You from Peeing

Imagine sitting on the toilet for 20 minutes, pushing hard, and nothing comes out. You feel full, maybe even painful, but your bladder just won’t empty. This isn’t just inconvenience - it’s a medical emergency called urinary retention. And for many people, especially men over 65, it’s not caused by an enlarged prostate alone. It’s caused by a common medication they’re taking for overactive bladder, anxiety, or allergies.

Anticholinergic drugs are everywhere. They’re in pills for overactive bladder like oxybutynin, tolterodine, solifenacin, and darifenacin. They’re in allergy meds like diphenhydramine (Benadryl), in antidepressants like amitriptyline, and even in some sleep aids. These drugs work by blocking acetylcholine, a chemical your body uses to tell your bladder to squeeze and empty. But when that signal gets blocked, your bladder can’t contract properly. The result? Urine builds up. And if it builds up too much, you can’t pee at all.

Why Your Bladder Needs Acetylcholine

Your bladder doesn’t just fill up and wait. It’s a complex system. When it’s time to urinate, nerves send a signal using acetylcholine to the detrusor muscle - the muscle in your bladder wall. That muscle contracts, squeezing the urine out. At the same time, the sphincter muscles that hold urine in relax. This whole dance happens in less than a second in healthy people.

Anticholinergics mess with this by blocking the M3 receptors - the specific spots on the bladder muscle that respond to acetylcholine. Without that signal, the muscle doesn’t squeeze hard enough. Even if your bladder is full, it stays relaxed. That’s why you feel the urge but can’t start peeing. In severe cases, your bladder becomes overdistended, the nerves get damaged, and you lose the sensation altogether.

Who’s Most at Risk?

This isn’t something that happens to everyone. Certain people are at much higher risk:

• Men over 65 with enlarged prostates (BPH): Their bladder outlet is already narrowed. Add an anticholinergic, and the bladder can’t generate enough force to push through. Studies show this group has a 4.3% risk of acute retention - over 8 times higher than younger men without prostate issues.
• Elderly patients on multiple medications: If you’re taking 3 or more drugs with anticholinergic effects (like a sleep aid, an allergy pill, and an OAB drug), your total “anticholinergic burden” skyrockets. A 2017 study found people with a score of 3 or higher on the Anticholinergic Cognitive Burden (ACB) scale had a 68% increased risk of urinary retention.
• People with dementia or Parkinson’s: Their nervous systems are already fragile. The Beers Criteria (2019 update) lists anticholinergics as “potentially inappropriate” for older adults because they can trigger retention, confusion, and falls.
• Women with pelvic floor weakness: While less common than in men, women with prior surgeries or nerve damage can also develop retention from these drugs.

A 2022 survey of 1,234 anticholinergic users found that 8.7% had to get a catheter because they couldn’t pee. For men, that number jumped to 12.3%. For women, it was 5.1%. The difference? Prostate size. It’s not just about age - it’s about anatomy.

Which Drugs Are the Worst?

Not all anticholinergics are created equal. Some are more likely to cause retention than others.

Why the difference? It comes down to receptor targeting. Oxybutynin blocks M1, M2, and M3 receptors - meaning it hits the bladder hard and also affects the brain and gut. That’s why it’s more likely to cause retention. Solifenacin and darifenacin are more selective - they mostly target M3, so they’re safer. But even the “safer” ones can still cause problems in vulnerable people.

The Real Cost - Emergency Rooms and Catheters

This isn’t a minor side effect. Acute urinary retention is a classic ER visit. You show up in pain, can’t pee, and they have to stick a catheter in. That’s uncomfortable. It’s expensive. And it’s preventable.

In the U.S., anticholinergic-induced retention costs the healthcare system $417 million a year in ER visits, hospital stays, and catheter supplies. The Veterans Affairs database found that 3.2% of all acute retention cases in men over 65 were caused by these drugs. When combined with opioids or other bladder-slowing meds? That number jumps to 12.7%.

One Reddit user, 71, described his ER trip after taking tolterodine: “I thought it was just constipation. Then I couldn’t pee for 18 hours. They had to catheterize me. My urologist said I got lucky - I could’ve ruptured my bladder.”

What Should You Do Instead?

If you’re on an anticholinergic and have any risk factors - especially if you’re a man with prostate issues - you have better options.

• Mirabegron (Myrbetriq): This drug doesn’t block acetylcholine. Instead, it relaxes the bladder muscle by activating beta-3 receptors. In clinical trials, it caused urinary retention in only 0.3% of users - less than a third of the anticholinergic rate.
• OnabotulinumtoxinA (Botox injections): Injected directly into the bladder wall, it temporarily paralyzes the muscle to reduce urgency. Retention risk? Only 0.5%. It’s not first-line, but it’s much safer than anticholinergics for high-risk men.
• Neuromodulation: Devices like InterStim stimulate nerves to improve bladder control. No drugs. No retention risk.

Market data shows this shift is already happening. In 2015, 58% of overactive bladder prescriptions were anticholinergics. By 2022, that dropped to 42%. Mirabegron now holds 31% of the market. Oxybutynin? Down to 18%. Doctors are learning: if you have a prostate, there’s a better way.

How to Stay Safe If You Must Take Them

Some people still need anticholinergics - especially women without prostate issues. But even then, safety matters.

1. Test your post-void residual (PVR) before starting. A simple bladder scanner measures how much urine is left after you pee. If it’s over 100 mL, don’t start the drug. If it’s over 150 mL, it’s a hard stop.
2. Monitor every 4 weeks for the first 3 months. Retention often happens in the first 30 days. A 2021 study found that home bladder scanners improved adherence by 92% and cut retention episodes by 61%.
3. Start low, go slow. Instead of a full 5 mg dose of solifenacin, start with 2.5 mg. Wait two weeks. Check your PVR again.
4. Combine with alpha-blockers if you have BPH. Drugs like tamsulosin relax the prostate and urethra. Together with a low-dose anticholinergic, they cut retention risk by 37%.
5. Use patches, not pills. The oxybutynin patch delivers less drug into your bloodstream. It lowers retention risk by 42% compared to oral forms.

One patient, CathyR, shared on HealthUnlocked: “I’ve been on solifenacin for 18 months. My urologist checks my PVR every month. When it hit 150 mL, we dropped my dose. I’ve never had a problem. It’s not about avoiding the drug - it’s about watching for warning signs.”

The Bottom Line

Anticholinergics aren’t evil. They help millions of people control urgent, frequent urination. But they’re not harmless. For men with enlarged prostates, older adults on multiple meds, or anyone with a history of bladder problems - these drugs can turn a manageable condition into a medical crisis.

The guidelines are clear: Don’t give anticholinergics to someone who already can’t empty their bladder. The American Urological Association says it bluntly: “Absolutely contraindicated.”

If you’re taking one of these drugs and you notice:

• Straining to pee
• A weak or slow stream
• Feeling like you still need to go after peeing
• Needing to go more than 8 times a day
• Not peeing for 12+ hours

- stop the drug and call your doctor. Don’t wait. Don’t hope it passes. This isn’t a side effect you can tough out. It’s a blockage that can damage your kidneys and bladder permanently.

There are safer, smarter ways to manage overactive bladder - especially if you’re a man over 65. Ask your doctor about mirabegron. Ask about bladder scans. Ask about alternatives. Your bladder will thank you.